# Ridgeback Biotherapeutics LP

Canonical: https://abierto.us/vendors/ridgeback-biotherapeutics-lp-j486ujlmakb5

- UEI: J486UJLMAKB5
- CAGE: 8B1C9
- Location: Miami, FL
- Awards in window: 2 (4 transactions), -$884,705 obligated, August 15, 2025 to June 10, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 2 awards, -$884,705

## Industries

- 541713 Research and Development in Nanotechnology: -$884,705

## Competition

- Not Competed: 2 awards

## Largest awards

- 75A50119C00059 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. Additional IN-SCOPE Work for CMC Efforts for MAB114 Development for the Treatment of Ebola.. https://www.usaspending.gov/award/CONT_AWD_75A50119C00059_7505_-NONE-_-NONE-/
- 75A50120C00009 (definitive contract): -$884,705, Barda - Aspr / Daappo / Barda DCMA. CMC Efforts for MAB114 for the Development and Treatment of Ebola.. https://www.usaspending.gov/award/CONT_AWD_75A50120C00009_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/ridgeback-biotherapeutics-lp-j486ujlmakb5.